Breakdown | |||||
TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|---|
Income Statement | Total Revenue | ||||
376.89B | 393.31B | 307.55B | 284.13B | 253.78B | 182.86B | Gross Profit |
264.65B | 277.45B | 208.64B | 184.51B | 154.01B | 106.88B | EBIT |
161.20B | 166.72B | 121.49B | 110.41B | 91.51B | 53.11B | EBITDA |
168.17B | 180.34B | 132.49B | 120.78B | 100.06B | 59.87B | Net Income Common Stockholders |
120.68B | 123.89B | 84.20B | 82.89B | 66.21B | 39.09B |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | ||||
263.49B | 229.17B | 215.49B | 163.05B | 125.77B | 109.81B | Total Assets |
628.79B | 654.09B | 556.06B | 468.80B | 404.54B | 329.03B | Total Debt |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | Net Debt |
-263.49B | -229.17B | -215.49B | -163.05B | -125.77B | -109.81B | Total Liabilities |
174.69B | 161.38B | 149.50B | 120.76B | 110.73B | 76.67B | Stockholders Equity |
453.77B | 492.36B | 406.37B | 347.80B | 293.54B | 252.14B |
Cash Flow | Free Cash Flow | ||||
23.68B | 52.41B | 81.27B | 67.53B | 40.02B | 35.60B | Operating Cash Flow |
28.01B | 120.36B | 97.52B | 81.78B | 83.65B | 56.71B | Investing Cash Flow |
-4.39B | -68.00B | -16.40B | -13.08B | -43.59B | -13.11B | Financing Cash Flow |
-4.09B | -38.15B | -30.94B | -32.09B | -27.19B | -15.82B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
$23.97B | 29.85 | 27.22% | 1.22% | ― | ― | ||
62 Neutral | $11.80B | 10.31 | -7.45% | 2.91% | 7.43% | -7.78% | |
$40.50B | 38.56 | 34.01% | 0.47% | ― | ― | ||
$7.29B | 11.27 | 24.78% | 2.69% | ― | ― | ||
$9.02B | 19.86 | 44.53% | 1.74% | ― | ― | ||
$23.50B | 21.72 | 7.22% | 1.40% | ― | ― | ||
63 Neutral | ¥341.06B | 19.06 | 2.16% | -0.96% | -42.79% |